Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Characteristics and roles of extracellular vesicles released by epidermal keratinocytes.

Than UTT, Leavesley DI, Parker TJ.

J Eur Acad Dermatol Venereol. 2019 Aug 12. doi: 10.1111/jdv.15859. [Epub ahead of print] Review.

PMID:
31403744
2.

Differential Expression of Keratinocyte-Derived Extracellular Vesicle Mirnas Discriminate Exosomes From Apoptotic Bodies and Microvesicles.

Than UTT, Guanzon D, Broadbent JA, Leavesley DI, Salomon C, Parker TJ.

Front Endocrinol (Lausanne). 2018 Sep 11;9:535. doi: 10.3389/fendo.2018.00535. eCollection 2018.

3.

A fence barrier method of leading edge cell capture for explorative biochemical research.

Wager LJ, Murray RZ, Thompson EW, Leavesley DI.

Cell Adh Migr. 2017 Sep 3;11(5-6):496-503. doi: 10.1080/19336918.2016.1269997. Epub 2017 Feb 17.

4.

Antagonists of IGF:Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell Functions.

Kashyap AS, Shooter GK, Shokoohmand A, McGovern J, Sivaramakrishnan M, Croll TI, Cane G, Leavesley DI, Söderberg O, Upton Z, Hollier BG.

Mol Cancer Ther. 2016 Jul;15(7):1602-13. doi: 10.1158/1535-7163.MCT-15-0907. Epub 2016 May 9. Erratum in: Mol Cancer Ther. 2016 Dec;15(12 ):3120.

5.

Functional and mechanistic investigation of Shikonin in scarring.

Xie Y, Fan C, Dong Y, Lynam E, Leavesley DI, Li K, Su Y, Yang Y, Upton Z.

Chem Biol Interact. 2015 Feb 25;228:18-27. doi: 10.1016/j.cbi.2014.12.037. Epub 2015 Jan 12.

PMID:
25591861
6.

Differential subcellular and extracellular localisations of proteins required for insulin-like growth factor- and extracellular matrix-induced signalling events in breast cancer progression.

Plant HC, Kashyap AS, Manton KJ, Hollier BG, Hurst CP, Stein SR, Francis GD, Beadle GF, Upton Z, Leavesley DI.

BMC Cancer. 2014 Aug 29;14:627. doi: 10.1186/1471-2407-14-627.

7.

Multiple types of data are required to identify the mechanisms influencing the spatial expansion of melanoma cell colonies.

Treloar KK, Simpson MJ, Haridas P, Manton KJ, Leavesley DI, McElwain DL, Baker RE.

BMC Syst Biol. 2013 Dec 12;7:137. doi: 10.1186/1752-0509-7-137.

8.

Vitronectin--master controller or micromanager?

Leavesley DI, Kashyap AS, Croll T, Sivaramakrishnan M, Shokoohmand A, Hollier BG, Upton Z.

IUBMB Life. 2013 Oct;65(10):807-18. doi: 10.1002/iub.1203. Epub 2013 Sep 13. Review.

9.

Quantifying the roles of cell motility and cell proliferation in a circular barrier assay.

Simpson MJ, Treloar KK, Binder BJ, Haridas P, Manton KJ, Leavesley DI, McElwain DL, Baker RE.

J R Soc Interface. 2013 Feb 20;10(82):20130007. doi: 10.1098/rsif.2013.0007. Print 2013 May 6.

10.

A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activity.

Parker TJ, Sampson DL, Broszczak D, Chng YL, Carter SL, Leavesley DI, Parker AW, Upton Z.

PLoS One. 2012;7(3):e33714. doi: 10.1371/journal.pone.0033714. Epub 2012 Mar 23.

11.

Effects of oxygen on zonal marker expression in human articular chondrocytes.

Schrobback K, Malda J, Crawford RW, Upton Z, Leavesley DI, Klein TJ.

Tissue Eng Part A. 2012 May;18(9-10):920-33. doi: 10.1089/ten.TEA.2011.0088. Epub 2012 Jan 4.

PMID:
22097912
12.

Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds.

Upton Z, Wallace HJ, Shooter GK, van Lonkhuyzen DR, Yeoh-Ellerton S, Rayment EA, Fleming JM, Broszczak D, Queen D, Sibbald RG, Leavesley DI, Stacey MC.

Int Wound J. 2011 Oct;8(5):522-32. doi: 10.1111/j.1742-481X.2011.00859.x.

PMID:
21914133
13.

Effects of oxygen and culture system on in vitro propagation and redifferentiation of osteoarthritic human articular chondrocytes.

Schrobback K, Klein TJ, Crawford R, Upton Z, Malda J, Leavesley DI.

Cell Tissue Res. 2012 Mar;347(3):649-63. doi: 10.1007/s00441-011-1193-7. Epub 2011 Jun 4.

PMID:
21638206
14.

Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin:growth factor complexes in wound healing applications.

Xie Y, Upton Z, Richards S, Rizzi SC, Leavesley DI.

J Control Release. 2011 Aug 10;153(3):225-32. doi: 10.1016/j.jconrel.2011.03.021. Epub 2011 Mar 30.

PMID:
21457738
15.

Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migration.

Kashyap AS, Hollier BG, Manton KJ, Satyamoorthy K, Leavesley DI, Upton Z.

Endocrinology. 2011 Apr;152(4):1388-401. doi: 10.1210/en.2010-0897. Epub 2011 Feb 8.

PMID:
21303956
16.

Adult human articular chondrocytes in a microcarrier-based culture system: expansion and redifferentiation.

Schrobback K, Klein TJ, Schuetz M, Upton Z, Leavesley DI, Malda J.

J Orthop Res. 2011 Apr;29(4):539-46. doi: 10.1002/jor.21264. Epub 2010 Oct 18.

17.

The effect of amphiphilic siloxane oligomers on fibroblast and keratinocyte proliferation and apoptosis.

Lynam EC, Xie Y, Loli B, Dargaville TR, Leavesley DI, George GA, Upton Z.

J Biomed Mater Res A. 2010 Nov;95(2):620-31. doi: 10.1002/jbm.a.32844.

PMID:
20725963
18.

Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin.

Kricker JA, Hyde CE, Van Lonkhuyzen DR, Hollier BG, Shooter GK, Leavesley DI, Herington AC, Upton Z.

Growth Factors. 2010 Oct;28(5):359-69. doi: 10.3109/08977194.2010.494603.

PMID:
20569097
19.

Development of a three-dimensional human skin equivalent wound model for investigating novel wound healing therapies.

Xie Y, Rizzi SC, Dawson R, Lynam E, Richards S, Leavesley DI, Upton Z.

Tissue Eng Part C Methods. 2010 Oct;16(5):1111-23. doi: 10.1089/ten.TEC.2009.0725.

PMID:
20109066
20.

Functional and phenotypic characterization of human keratinocytes expanded in microcarrier culture.

Borg DJ, Dawson RA, Leavesley DI, Hutmacher DW, Upton Z, Malda J.

J Biomed Mater Res A. 2009 Jan;88(1):184-94. doi: 10.1002/jbm.a.31864.

PMID:
18286639
21.

Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors.

Van Lonkhuyzen DR, Hollier BG, Shooter GK, Leavesley DI, Upton Z.

Growth Factors. 2007 Oct;25(5):295-308. doi: 10.1080/08977190701803752.

PMID:
18236208
22.

Vitronectin: growth factor complexes hold potential as a wound therapy approach.

Upton Z, Cuttle L, Noble A, Kempf M, Topping G, Malda J, Xie Y, Mill J, Harkin DG, Kravchuk O, Leavesley DI, Kimble RM.

J Invest Dermatol. 2008 Jun;128(6):1535-44. doi: 10.1038/sj.jid.5701148. Epub 2008 Jan 17.

24.

Mediation of biomaterial-cell interactions by adsorbed proteins: a review.

Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ.

Tissue Eng. 2005 Jan-Feb;11(1-2):1-18. Review.

PMID:
15738657
25.

Traveling wave model to interpret a wound-healing cell migration assay for human peritoneal mesothelial cells.

Maini PK, McElwain DL, Leavesley DI.

Tissue Eng. 2004 Mar-Apr;10(3-4):475-82.

PMID:
15165464
26.

Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis.

Zarrinkalam KH, Leavesley DI, Stanley JM, Atkins GJ, Faull RJ.

Perit Dial Int. 2001 Sep-Oct;21(5):501-8.

PMID:
11757835
27.

HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration.

Faull RJ, Stanley JM, Fraser S, Power DA, Leavesley DI.

Kidney Int. 2001 Feb;59(2):614-24.

29.
30.

Specificity and functional effects of antibodies to human stem cell factor.

Zannettino AC, Aylett GW, Leavesley DI, Pietsch T, Chang DG, Simmons PJ, Ashman LK.

Growth Factors. 1997;14(1):67-79.

PMID:
9086329
31.

A novel activating anti-beta1 integrin monoclonal antibody binds to the cysteine-rich repeats in the beta1 chain.

Faull RJ, Wang J, Leavesley DI, Puzon W, Russ GR, Vestweber D, Takada Y.

J Biol Chem. 1996 Oct 11;271(41):25099-106.

32.

Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins.

Lévesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ.

J Exp Med. 1995 May 1;181(5):1805-15.

33.

Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells.

Leavesley DI, Oliver JM, Swart BW, Berndt MC, Haylock DN, Simmons PJ.

J Immunol. 1994 Nov 15;153(10):4673-83.

PMID:
7525710
34.

The mobilization of primitive hemopoietic progenitors into the peripheral blood.

Simmons PJ, Leavesley DI, Levesque JP, Swart BW, Haylock DN, To LB, Ashman LK, Juttner CA.

Stem Cells. 1994;12 Suppl 1:187-201; discussion 201-2. Review.

PMID:
7535145
35.

Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms.

Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA.

J Cell Biol. 1993 Apr;121(1):163-70.

36.

Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen.

Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA.

J Cell Biol. 1992 Jun;117(5):1101-7.

38.

Purification of the 25-kDa Vibrio cholerae major outer-membrane protein and the molecular cloning of its gene: ompV.

Stevenson G, Leavesley DI, Lagnado CA, Heuzenroeder MW, Manning PA.

Eur J Biochem. 1985 Apr 15;148(2):385-90.

Supplemental Content

Loading ...
Support Center